日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

First-in-Human Phase I Trial to Assess the Safety and Immunogenicity of an Orf Virus-Based COVID-19 Vaccine Booster.

首次人体 I 期试验,评估基于羊痘病毒的 COVID-19 疫苗加强针的安全性和免疫原性

Esen Meral, Fischer-Herr Johanna, Gabor Julian Justin, Gaile Johanna Marika, Fleischmann Wim Alexander, Smeenk Geerten Willem, de Moraes Roberta Allgayer, Bélard Sabine, Calle Carlos Lamsfus, Woldearegai Tamirat Gebru, Egger-Adam Diane, Haug Verena, Metz Carina, Reguzova Alena, Löffler Markus W, Balode Baiba, Matthies Lars C, Ramharter Michael, Amann Ralf, Kremsner Peter G

Immunogenicity and safety of an inactivated 2012/2013 trivalent influenza vaccine produced in mammalian cell culture (Optaflu®): an open label, uncontrolled study

哺乳动物细胞培养生产的2012/2013三价灭活流感疫苗(Optaflu®)的免疫原性和安全性:一项开放标签、非对照研究

Vinnemeier, Christof David; Fischer-Herr, Johanna; Meyer, Seetha; Liebig, Katja; Theeß, Wiebke; Burchard, Gerd-Dieter; Cramer, Jakob P

Disease-associated QT-shortage versus quinine associated QT-prolongation: age dependent ECG-effects in Ghanaian children with severe malaria

疾病相关的QT间期缩短与奎宁相关的QT间期延长:加纳重症疟疾患儿的年龄依赖性心电图效应

Roggelin, Louise; Pelletier, Daniel; Hill, Josephine N; Feldt, Torsten; Hoffmann, Steffi; Ansong, Daniel; Sylverken, Justice; Burhenne, Jürgen; Fischer-Herr, Johanna; Mehrfar, Parisa; Thiel, Christian; Burchard, Gerd D; Nguah, Samuel B; Cramer, Jakob P

Clinical relevance of different biomarkers in imported plasmodium falciparum malaria in adults: a case control study

不同生物标志物在成人输入性恶性疟原虫疟疾中的临床意义:一项病例对照研究

Stauga, Sabine; Hahn, Andreas; Brattig, Norbert W; Fischer-Herr, Johanna; Baldus, Stephan; Burchard, Gerd D; Cramer, Jakob P